Annual Shareholders Equity
$232.17 M
-$21.80 M-8.58%
31 December 2023
Summary:
MaxCyte annual stockholders equity is currently $232.17 million, with the most recent change of -$21.80 million (-8.58%) on 31 December 2023. During the last 3 years, it has fallen by -$30.73 million (-11.69%). MXCT annual shareholders equity is now -11.69% below its all-time high of $262.90 million, reached on 31 December 2021.MXCT Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$213.30 M
-$7.96 M-3.60%
30 September 2024
Summary:
MaxCyte quarterly stockholders equity is currently $213.30 million, with the most recent change of -$7.96 million (-3.60%) on 30 September 2024. Over the past year, it has dropped by -$18.86 million (-8.13%). MXCT quarterly shareholders equity is now -19.24% below its all-time high of $264.12 million, reached on 30 September 2021.MXCT Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MXCT Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -8.1% |
| 3 y3 years | -11.7% | -18.9% |
| 5 y5 years | +1606.9% | +1468.2% |
MXCT Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -11.7% | at low | -18.9% | at low |
| 5 y | 5 years | -11.7% | +1606.9% | -19.2% | +1468.2% |
| alltime | all time | -11.7% | +7631.8% | -19.2% | +7019.8% |
MaxCyte Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $213.30 M(-3.6%) |
| June 2024 | - | $221.26 M(-2.3%) |
| Mar 2024 | - | $226.36 M(-2.5%) |
| Dec 2023 | $232.17 M(-8.6%) | $232.17 M(-0.5%) |
| Sept 2023 | - | $233.38 M(-3.2%) |
| June 2023 | - | $240.98 M(-2.8%) |
| Mar 2023 | - | $247.82 M(-2.4%) |
| Dec 2022 | $253.97 M(-3.4%) | $253.97 M(-0.2%) |
| Sept 2022 | - | $254.43 M(-1.1%) |
| June 2022 | - | $257.22 M(-1.9%) |
| Mar 2022 | - | $262.18 M(-0.3%) |
| Dec 2021 | $262.90 M(+691.3%) | $262.90 M(-0.5%) |
| Sept 2021 | - | $264.12 M(+235.1%) |
| June 2021 | - | $78.82 M(+137.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $33.23 M(+144.3%) | $33.23 M(-10.7%) |
| June 2020 | - | $37.21 M(+173.6%) |
| Dec 2019 | $13.60 M(+10.7%) | $13.60 M(-15.4%) |
| June 2019 | - | $16.08 M(+30.9%) |
| Dec 2018 | $12.28 M(-37.3%) | $12.28 M(-20.0%) |
| June 2018 | - | $15.35 M(-21.7%) |
| Dec 2017 | $19.60 M(+285.5%) | $19.60 M(-21.0%) |
| June 2017 | - | $24.81 M(+388.0%) |
| Dec 2016 | $5.08 M(-264.9%) | $5.08 M(-28.1%) |
| June 2016 | - | $7.07 M(-329.3%) |
| Dec 2015 | -$3.08 M(+87.1%) | -$3.08 M(-135.7%) |
| June 2015 | - | $8.64 M(-624.5%) |
| Dec 2014 | -$1.65 M(+6.7%) | -$1.65 M |
| Dec 2013 | -$1.54 M(+161.2%) | - |
| Dec 2012 | -$590.70 K | - |
FAQ
- What is MaxCyte annual stockholders equity?
- What is the all time high annual shareholders equity for MaxCyte?
- What is MaxCyte quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for MaxCyte?
- What is MaxCyte quarterly shareholders equity year-on-year change?
What is MaxCyte annual stockholders equity?
The current annual shareholders equity of MXCT is $232.17 M
What is the all time high annual shareholders equity for MaxCyte?
MaxCyte all-time high annual stockholders equity is $262.90 M
What is MaxCyte quarterly stockholders equity?
The current quarterly shareholders equity of MXCT is $213.30 M
What is the all time high quarterly shareholders equity for MaxCyte?
MaxCyte all-time high quarterly stockholders equity is $264.12 M
What is MaxCyte quarterly shareholders equity year-on-year change?
Over the past year, MXCT quarterly stockholders equity has changed by -$18.86 M (-8.13%)